BDKRB1 anticorps
-
- Antigène Voir toutes BDKRB1 Anticorps
- BDKRB1 (Bradykinin Receptor B1 (BDKRB1))
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp BDKRB1 est non-conjugé
-
Application
- Western Blotting (WB)
- Purification
- Affinity purification
- Immunogène
- A synthetic peptide of human BDKRB1
- Isotype
- IgG
- Top Product
- Discover our top product BDKRB1 Anticorps primaire
-
-
- Indications d'application
- WB 1:500 - 1:2000
- Restrictions
- For Research Use only
-
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20C. Avoid freeze / thaw cycles.
-
- Antigène
- BDKRB1 (Bradykinin Receptor B1 (BDKRB1))
- Autre désignation
- BDKRB1 (BDKRB1 Produits)
- Synonymes
- anticorps bdkrb2, anticorps LOC100230525, anticorps B1BKR, anticorps B1R, anticorps BKB1R, anticorps BKR1, anticorps BRADYB1, anticorps BKR, anticorps Bdkrb, anticorps b1bkr, anticorps bradykinin receptor B1, anticorps bradykinin receptor, beta 1, anticorps bdkrb1, anticorps BDKRB1, anticorps Bdkrb1
- Sujet
- Bradykinin, a 9 aa peptide, is generated in pathophysiologic conditions such as inflammation, trauma, burns, shock, and allergy. Two types of G-protein coupled receptors have been found which bind bradykinin and mediate responses to these pathophysiologic conditions. The protein encoded by this gene is one of these receptors and is synthesized de novo following tissue injury. Receptor binding leads to an increase in the cytosolic calcium ion concentration, ultimately resulting in chronic and acute inflammatory responses. Several transcript variants encoding different isoforms have been found for this gene.
- Poids moléculaire
- 40.495 kDa
- ID gène
- 623
- UniProt
- P46663
- Pathways
- ACE Inhibitor Pathway
-